Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation

Tarun Chakravarty, Eric Van Belle, Hasan Jilaihawi, Amit Noheria, Luca Testa, Francesco Bedogni, Andreas Rück, Marco Barbanti, Stefan Toggweiler, Martyn Thomas, Muhammed Z eeshan Khawaja, Andrea Hutter, Yigal Abramowitz, Robert J. Siegel, Wen Cheng, John Webb, Martin B. Leon, Raj R. Makkar

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Significant mitral regurgitation (MR) constitutes an important co-existing valvular heart disease burden in the setting of aortic valve stenosis. There are conflicting reports on the impact of significant MR on outcomes after transcatheter aortic valve implantation (TAVI). We evaluated the impact of MR on outcomes after TAVI by performing a meta-analysis of 8 studies involving 8,927 patients reporting TAVI outcomes based on the presence or absence of moderate-severe MR. Risk ratios (RRs) were calculated using the inverse variance random-effects model. None-mild MR was present in 77.8% and moderate-severe MR in 22.2% of the patients. The presence of moderate-severe MR at baseline was associated with increased mortality at 30 days (RR 1.35, 95% confidence interval [CI] 1.14 to 1.59, p = 0.003) and 1 year (RR 1.24, 95% CI 1.13 to 1.37, p

Original languageEnglish
Pages (from-to)942-949
Number of pages8
JournalThe American Journal of Cardiology
Volume115
Issue number7
DOIs
Publication statusPublished - Apr 1 2015

Fingerprint

Mitral Valve Insufficiency
Meta-Analysis
Odds Ratio
Confidence Intervals
Heart Valve Diseases
Aortic Valve Stenosis
Transcatheter Aortic Valve Replacement
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. / Chakravarty, Tarun; Van Belle, Eric; Jilaihawi, Hasan; Noheria, Amit; Testa, Luca; Bedogni, Francesco; Rück, Andreas; Barbanti, Marco; Toggweiler, Stefan; Thomas, Martyn; Khawaja, Muhammed Z eeshan; Hutter, Andrea; Abramowitz, Yigal; Siegel, Robert J.; Cheng, Wen; Webb, John; Leon, Martin B.; Makkar, Raj R.

In: The American Journal of Cardiology, Vol. 115, No. 7, 01.04.2015, p. 942-949.

Research output: Contribution to journalArticle

Chakravarty, T, Van Belle, E, Jilaihawi, H, Noheria, A, Testa, L, Bedogni, F, Rück, A, Barbanti, M, Toggweiler, S, Thomas, M, Khawaja, MZE, Hutter, A, Abramowitz, Y, Siegel, RJ, Cheng, W, Webb, J, Leon, MB & Makkar, RR 2015, 'Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation', The American Journal of Cardiology, vol. 115, no. 7, pp. 942-949. https://doi.org/10.1016/j.amjcard.2015.01.022
Chakravarty, Tarun ; Van Belle, Eric ; Jilaihawi, Hasan ; Noheria, Amit ; Testa, Luca ; Bedogni, Francesco ; Rück, Andreas ; Barbanti, Marco ; Toggweiler, Stefan ; Thomas, Martyn ; Khawaja, Muhammed Z eeshan ; Hutter, Andrea ; Abramowitz, Yigal ; Siegel, Robert J. ; Cheng, Wen ; Webb, John ; Leon, Martin B. ; Makkar, Raj R. / Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. In: The American Journal of Cardiology. 2015 ; Vol. 115, No. 7. pp. 942-949.
@article{df17542c2849483ab4bc6f52067707e0,
title = "Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation",
abstract = "Significant mitral regurgitation (MR) constitutes an important co-existing valvular heart disease burden in the setting of aortic valve stenosis. There are conflicting reports on the impact of significant MR on outcomes after transcatheter aortic valve implantation (TAVI). We evaluated the impact of MR on outcomes after TAVI by performing a meta-analysis of 8 studies involving 8,927 patients reporting TAVI outcomes based on the presence or absence of moderate-severe MR. Risk ratios (RRs) were calculated using the inverse variance random-effects model. None-mild MR was present in 77.8{\%} and moderate-severe MR in 22.2{\%} of the patients. The presence of moderate-severe MR at baseline was associated with increased mortality at 30 days (RR 1.35, 95{\%} confidence interval [CI] 1.14 to 1.59, p = 0.003) and 1 year (RR 1.24, 95{\%} CI 1.13 to 1.37, p",
author = "Tarun Chakravarty and {Van Belle}, Eric and Hasan Jilaihawi and Amit Noheria and Luca Testa and Francesco Bedogni and Andreas R{\"u}ck and Marco Barbanti and Stefan Toggweiler and Martyn Thomas and Khawaja, {Muhammed Z eeshan} and Andrea Hutter and Yigal Abramowitz and Siegel, {Robert J.} and Wen Cheng and John Webb and Leon, {Martin B.} and Makkar, {Raj R.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.amjcard.2015.01.022",
language = "English",
volume = "115",
pages = "942--949",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation

AU - Chakravarty, Tarun

AU - Van Belle, Eric

AU - Jilaihawi, Hasan

AU - Noheria, Amit

AU - Testa, Luca

AU - Bedogni, Francesco

AU - Rück, Andreas

AU - Barbanti, Marco

AU - Toggweiler, Stefan

AU - Thomas, Martyn

AU - Khawaja, Muhammed Z eeshan

AU - Hutter, Andrea

AU - Abramowitz, Yigal

AU - Siegel, Robert J.

AU - Cheng, Wen

AU - Webb, John

AU - Leon, Martin B.

AU - Makkar, Raj R.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Significant mitral regurgitation (MR) constitutes an important co-existing valvular heart disease burden in the setting of aortic valve stenosis. There are conflicting reports on the impact of significant MR on outcomes after transcatheter aortic valve implantation (TAVI). We evaluated the impact of MR on outcomes after TAVI by performing a meta-analysis of 8 studies involving 8,927 patients reporting TAVI outcomes based on the presence or absence of moderate-severe MR. Risk ratios (RRs) were calculated using the inverse variance random-effects model. None-mild MR was present in 77.8% and moderate-severe MR in 22.2% of the patients. The presence of moderate-severe MR at baseline was associated with increased mortality at 30 days (RR 1.35, 95% confidence interval [CI] 1.14 to 1.59, p = 0.003) and 1 year (RR 1.24, 95% CI 1.13 to 1.37, p

AB - Significant mitral regurgitation (MR) constitutes an important co-existing valvular heart disease burden in the setting of aortic valve stenosis. There are conflicting reports on the impact of significant MR on outcomes after transcatheter aortic valve implantation (TAVI). We evaluated the impact of MR on outcomes after TAVI by performing a meta-analysis of 8 studies involving 8,927 patients reporting TAVI outcomes based on the presence or absence of moderate-severe MR. Risk ratios (RRs) were calculated using the inverse variance random-effects model. None-mild MR was present in 77.8% and moderate-severe MR in 22.2% of the patients. The presence of moderate-severe MR at baseline was associated with increased mortality at 30 days (RR 1.35, 95% confidence interval [CI] 1.14 to 1.59, p = 0.003) and 1 year (RR 1.24, 95% CI 1.13 to 1.37, p

UR - http://www.scopus.com/inward/record.url?scp=84929513917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929513917&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2015.01.022

DO - 10.1016/j.amjcard.2015.01.022

M3 - Article

C2 - 25779617

AN - SCOPUS:84929513917

VL - 115

SP - 942

EP - 949

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 7

ER -